CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories

Original Research2019 Feb;7(2):132-142.

JOURNAL:JACC Heart Fail. Article Link

3D Printing and Heart Failure: The Present and the Future

Farooqi KM, Cooper C, Chelliah A et al. Keywords: 3D printing; cardiac computed tomography; cardiac magnetic resonance; heart failure

ABSTRACT


Advanced imaging modalities provide essential anatomic and spatial information in patients with complex heart disease. Two-dimensional imaging can be limited in the extent to which true 3-dimensional (3D) relationships are represented. The application of 3D printing technology has increased the creation of physical models that overcomes the limitations of a 2D screen. Many groups have reported the use of 3D printing for preprocedural planning in patients with different causes of heart failure. This paper reviews the innovative applications of this technique to provide patient-specific models to improve patient care.